The disease doesn’t have any FDA approved treatments, leaving families desperate for FDA to approve the treatment.

The global biotherapeutics company announced that it will seek to streamline operations as part of a broader transformation ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...

Pharma can embrace product iteration over one-time launches—and enhance agility and responsiveness through effective roadmaps ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...

Tonmya is the first new fibromyalgia therapy approved in over 15 years, targeting nonrestorative sleep to alleviate core ...

Vanda Pharmaceuticals won a legal battle as a federal court overturned the FDA's rejection of Hetlioz for jet lag disorder, ...

NIH's new strategy emphasizes transparency, prioritizes urgent health needs, and shifts focus to domestic research and ...

How a layered approach—tapping new avenues from earned media—can go a long way in boosting the brand engagement interplay ...